| Name | eIF4E-IN-2 |
|---|---|
| Synonyms |
Thieno[3,2-b]pyridine-3-cboxamide, 7-[5-chloro-2-[3-[5-cyano-6-[[1-(3,3-difluorocyclobutyl)-4-piperidinyl]methylamino]-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl]-1-propyn-1-yl]phenyl]-N-(methylsulfonyl)
7-(5-chloro-2-(3-(5-cyano-6-((1-(3,3-difluorocyclobutyl)piperidin-4-yl)(methyl)amino)-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)prop-1-yn-1-yl)phenyl)-N-(methylsulfonyl)thieno[3,2-b]pyridine-3-cboxamide |
| Description | eIF4E-IN-2 is a potent inhibitor of eukaryotic initiation factor 4e (eIF4e). eIF4E-IN-2 has the potential for researching eIF4e dependent diseases, including the research of cancer (extracted from patent WO2021003157A1, compound 1188)[1]. |
|---|---|
| Related Catalog | |
| Target |
eIF4e[1] |
| References |
| Molecular Formula | C37H33ClF2N8O4S2 |
|---|---|
| Molecular Weight | 791.29 |